Biotronik introduces Solia S ProMRI in US

19 June 2016 (Last Updated June 19th, 2016 18:30)

German medical technology company Biotronik has introduced its smallest MR conditional pacing lead, Solia S ProMRI in the US.

BiotroniK

German medical technology company Biotronik has introduced its smallest MR conditional pacing lead, Solia S ProMRI in the US.

The Solia S ProMRI features a 5.6 French lead body structure and is available in three size configurations which are 45cm, 53cm and 60cm in length.

University of California, San Diego School of Medicine professor of medicine and UC San Diego Health pacemaker and ICD services director Ulrika Birgersdotter-Green said: "Because there is a wide range of patient anatomy types, it is necessary to have various lead lengths to ensure the best outcomes.

"There have been, however, limitations in the variety of leads available, so this new technology will offer a more versatile lead and improve procedures."

"This new technology will offer a more versatile lead and improve procedures."

The MR conditional pacing lead is based on the ProMRI technology which enables the patients with pacemaker, implantable defibrillator, cardiac monitor, or cardiac resynchronisation therapy defibrillator (CRT-D) to undergo an MRI scan.

The Solia S ProMRI is supplemented with a polyurethane coating over silicone which is intended to reduce friction while allowing an easier application of Solia through small vessels and complex anatomy.

Its soft distal segment is designed to help reduce stress and decrease myocardial trauma.

A pre-market study (IDE) phase of the SIELLO clinical study had tested 1,758 patients at 60 US sites with 3,220 implanted Solia leads and ascertained the primary safety and efficacy of the device.


Image: Biotronik's Solia S ProMRI. Photo: courtesy of Biotronik.